fig8

Shared genetic architecture between metabolic dysfunction-associated steatotic liver disease and cardiometabolic traits comorbidities: a genome-wide pleiotropic and multi-omics study

Figure 8. Sankey diagram visualizing the relationships between trait pairs, genes, drugs, and classifications concerning MASLD and cardiometabolic comorbidities. MASLD: Metabolic dysfunction-associated steatotic liver disease; nonHDLC: non-HDL cholesterol; TG: triglyceride; AAA: abdominal aortic aneurysm; WHRadjBMI: WHR adjusted for BMI; WHR: waist-to-hip ratio; BMI: body mass index; T2D: type 2 diabetes.

Metabolism and Target Organ Damage
ISSN 2769-6375 (Online)
Follow Us

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/